Renal Cell Carcinoma
|
0.410 |
Biomarker
|
disease |
HPO |
|
|
|
Renal Cell Carcinoma
|
0.410 |
Biomarker
|
disease |
CTD_human |
|
|
|
Conventional (Clear Cell) Renal Cell Carcinoma
|
0.320 |
Biomarker
|
disease |
CTD_human |
|
|
|
Chromophobe Renal Cell Carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Sarcomatoid Renal Cell Carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Collecting Duct Carcinoma of the Kidney
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Papillary Renal Cell Carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Hereditary clear cell renal cell carcinoma
|
0.300 |
FusionGene
|
disease |
ORPHANET |
|
|
|
Isolated cases
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Neoplasms
|
0.060 |
Biomarker
|
group |
BEFREE |
On the basis of its chromosomal position, HRCA1 may be a candidate tumor suppressor gene.
|
7690964 |
1993 |
Globoid cell leukodystrophy
|
0.010 |
Biomarker
|
disease |
BEFREE |
Ultrastructurally immunogold deposits only of RCA-I and WGA in the typical Krabbe's inclusions have been clearly demonstrated.
|
1335383 |
1993 |
HEREDITARY RENAL CANCER ASSOCIATED 1
|
0.010 |
Biomarker
|
disease |
BEFREE |
We have identified a gene, referred to as HRCA1 (hereditary renal cancer associated 1), that maps immediately adjacent to the breakpoint.
|
7690964 |
1993 |
Carcinoma, Basal Cell
|
0.020 |
Biomarker
|
disease |
BEFREE |
We now show that the 8q24.1 breakpoint region encodes a 664-aa multiple membrane spanning protein, TRC8, with similarity to the hereditary basal cell carcinoma/segment polarity gene, patched.
|
9689122 |
1998 |
Experimental Organism Basal Cell Carcinoma
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
We now show that the 8q24.1 breakpoint region encodes a 664-aa multiple membrane spanning protein, TRC8, with similarity to the hereditary basal cell carcinoma/segment polarity gene, patched.
|
9689122 |
1998 |
Malignant neoplasm of kidney
|
0.040 |
Biomarker
|
disease |
BEFREE |
Thus, VHL, TRC8, and JAB1 appear to be linked both physically and functionally and all three may participate in the development of kidney cancer.
|
12032852 |
2002 |
Renal carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
Thus, VHL, TRC8, and JAB1 appear to be linked both physically and functionally and all three may participate in the development of kidney cancer.
|
12032852 |
2002 |
Medullary carcinoma of thyroid
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We previously reported that the TRC8 gene was interrupted by a t(3;8) translocation in a family with hereditary renal and non-medullary thyroid cancer.
|
12032852 |
2002 |
Renal Cell Carcinoma
|
0.410 |
Biomarker
|
disease |
BEFREE |
TRC8 encodes an E3-ubiquitin ligase disrupted in a family with hereditary renal cell carcinoma (RCC).
|
15735686 |
2005 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
0.320 |
Biomarker
|
disease |
BEFREE |
TRC8 encodes an E3-ubiquitin ligase disrupted in a family with hereditary renal cell carcinoma (RCC).
|
15735686 |
2005 |
Malignant neoplasm of kidney
|
0.040 |
Biomarker
|
disease |
BEFREE |
Growth suppression induced by the TRC8 hereditary kidney cancer gene is dependent upon JAB1/CSN5.
|
15735686 |
2005 |
Renal carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
Growth suppression induced by the TRC8 hereditary kidney cancer gene is dependent upon JAB1/CSN5.
|
15735686 |
2005 |
Hereditary Renal Cell Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
TRC8 encodes an E3-ubiquitin ligase disrupted in a family with hereditary renal cell carcinoma (RCC).
|
15735686 |
2005 |
Refractory Cytopenia of Childhood
|
0.010 |
Biomarker
|
disease |
BEFREE |
TRC8 encodes an E3-ubiquitin ligase disrupted in a family with hereditary renal cell carcinoma (RCC).
|
15735686 |
2005 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
A constitutional balanced t(3;8)(p14;q24.1) translocation results in disruption of the TRC8 gene and predisposition to clear cell renal cell carcinoma.
|
17539022 |
2007 |
Neoplasms
|
0.060 |
Biomarker
|
group |
BEFREE |
The presence of diploid and tetraploid tumor cells with and without TRC8 deletions on the nontranslocated chromosome suggest that loss of the remaining normal allele of TRC8 may contribute to tumor development at later stages.
|
17539022 |
2007 |